Prophase Labs Inc (PRPH)

$0.29 +0.01 (2.75%)
Market Cap 12.07M
Revenue (ttm) 6.77M
Net Income (ttm) -53.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -788.18%
Debt to Equity Ratio 0.15
Volume 552,200
Avg Vol 12,264,344
Day's Range N/A - N/A
Shares Out 41.88M
Stochastic %K 26%
Beta -0.56
Analysts Strong Buy
Price Target $11.00

Latest News on PRPH

ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 9:08 PM EDT - 20 days ago

ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript

ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024

Mar 31, 2025, 8:00 AM EDT - 20 days ago

ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024

ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025

Mar 27, 2025, 8:27 AM EDT - 24 days ago

ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025

ProPhase Labs to Present at the Investor Summit Virtual on March 11

Mar 7, 2025, 8:00 AM EST - 6 weeks ago

ProPhase Labs to Present at the Investor Summit Virtual on March 11

Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)

Feb 26, 2025, 8:00 AM EST - 7 weeks ago

Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)

ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs

Feb 25, 2025, 8:00 AM EST - 7 weeks ago

ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs

ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables

Feb 20, 2025, 8:00 AM EST - 2 months ago

ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables

ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports

Feb 18, 2025, 8:00 AM EST - 2 months ago

ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports

ProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 2:49 PM EST - 5 months ago

ProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript

ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024

Nov 11, 2024, 9:52 AM EST - 5 months ago

ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024

ProPhase Labs Announces Pricing of Public Offering of Common Stock

Nov 7, 2024, 11:37 PM EST - 5 months ago

ProPhase Labs Announces Pricing of Public Offering of Common Stock

ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025

Oct 17, 2024, 8:00 AM EDT - 6 months ago

ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025

ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event

Aug 19, 2024, 11:10 AM EDT - 8 months ago

ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event

ProPhase Labs, Inc. (PRPH) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 3:03 PM EDT - 8 months ago

ProPhase Labs, Inc. (PRPH) Q2 2024 Earnings Call Transcript

PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14

Aug 7, 2024, 8:00 AM EDT - 9 months ago

PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14

ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress

Jul 11, 2024, 8:00 AM EDT - 10 months ago

ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress

ProPhase Labs: Hidden Gem With An AI Kicker

May 15, 2024, 10:43 AM EDT - 1 year ago

ProPhase Labs: Hidden Gem With An AI Kicker

ProPhase Labs, Inc. (PRPH) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:47 PM EDT - 1 year ago

ProPhase Labs, Inc. (PRPH) Q1 2024 Earnings Call Transcript

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated

May 9, 2024, 3:40 PM EDT - 1 year ago

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Apr 25, 2024, 8:00 AM EDT - 1 year ago

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

ProPhase Labs Unveils Project ZenQ-AI

Apr 16, 2024, 8:00 AM EDT - 1 year ago

ProPhase Labs Unveils Project ZenQ-AI

ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024

Apr 10, 2024, 8:00 AM EDT - 1 year ago

ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 1, 2024, 9:00 PM EDT - 1 year ago

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript

Mar 15, 2024, 5:45 PM EDT - 1 year ago

ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript

ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives

Mar 15, 2024, 8:00 AM EDT - 1 year ago

ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives

PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024

Mar 8, 2024, 8:00 AM EST - 1 year ago

PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024

ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir

Feb 14, 2024, 8:00 AM EST - 1 year ago

ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir

Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts

Jan 23, 2024, 8:00 AM EST - 1 year ago

Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts

ProPhase Labs, Inc. (PRPH) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:11 PM EST - 1 year ago

ProPhase Labs, Inc. (PRPH) Q3 2023 Earnings Call Transcript

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

Nov 2, 2023, 8:00 AM EDT - 1 year ago

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.

Oct 17, 2023, 8:00 AM EDT - 1 year ago

ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.

ProPhase Labs to Present at The ThinkEquity Conference

Oct 12, 2023, 8:00 AM EDT - 1 year ago

ProPhase Labs to Present at The ThinkEquity Conference

ProPhase Labs, Inc. (PRPH) Q2 2023 Earnings Call Transcript

Aug 12, 2023, 11:04 AM EDT - 1 year ago

ProPhase Labs, Inc. (PRPH) Q2 2023 Earnings Call Transcript

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.

Aug 10, 2023, 10:40 AM EDT - 1 year ago

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.

ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time

Aug 2, 2023, 8:00 AM EDT - 1 year ago

ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time

Navidea Biopharmaceuticals rejects ProPhase Labs offer

Jun 30, 2023, 9:44 AM EDT - 1 year ago

Navidea Biopharmaceuticals rejects ProPhase Labs offer

ProPhase Labs Inc. Sets the Course for Expansion into the MENA Region with Cutting-Edge Genomic and Diagnostics Technologies

Jun 22, 2023, 8:30 AM EDT - 1 year ago

ProPhase Labs Inc. Sets the Course for Expansion into the MENA Region with Cutting-Edge Genomic and Diagnostics Technologies

ProPhase Labs Continues To Make The Right Moves - Reiterate Strong Buy

Jun 11, 2023, 1:16 AM EDT - 2 years ago

ProPhase Labs Continues To Make The Right Moves - Reiterate Strong Buy

ProPhase Labs to Present at the Diamond Equity Research Emerging Growth Invitational on Tuesday, June 13, 2023

Jun 7, 2023, 8:00 AM EDT - 2 years ago

ProPhase Labs to Present at the Diamond Equity Research Emerging Growth Invitational on Tuesday, June 13, 2023

ProPhase Labs' Cancer Therapeutic, Linebacker-1, pre-clinical studies with Dana Farber/Harvard Cancer Institute demonstrate impressive utility and move into next phase of testing

Jun 1, 2023, 8:30 AM EDT - 2 years ago

ProPhase Labs' Cancer Therapeutic, Linebacker-1, pre-clinical studies with Dana Farber/Harvard Cancer Institute demonstrate impressive utility and move into next phase of testing

ProPhase Labs, Inc. (PRPH) Q1 2023 Earnings Call Transcript

May 11, 2023, 4:10 PM EDT - 2 years ago

ProPhase Labs, Inc. (PRPH) Q1 2023 Earnings Call Transcript

ProPhase Labs hires Dr. Matthew Halpert to Drive Company's Key Therapeutic and Diagnostic Oncology Programs

May 8, 2023, 8:30 AM EDT - 2 years ago

ProPhase Labs hires Dr. Matthew Halpert to Drive Company's Key Therapeutic and Diagnostic Oncology Programs

ProPhase Labs' Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers

May 3, 2023, 8:30 AM EDT - 2 years ago

ProPhase Labs' Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers

ProPhase Labs CEO Ted Karkus Named One of Inc Magazine's 10 Most Innovative Healthcare Leaders to Watch in 2023

Apr 28, 2023, 8:30 AM EDT - 2 years ago

ProPhase Labs CEO Ted Karkus Named One of Inc Magazine's 10 Most Innovative Healthcare Leaders to Watch in 2023

ProPhase Labs Announces Launch of Redesigned Corporate Website

Apr 25, 2023, 8:30 AM EDT - 2 years ago

ProPhase Labs Announces Launch of Redesigned Corporate Website

ProPhase Labs, Inc. (PRPH) Q4 2022 Earnings Call Transcript

Mar 28, 2023, 3:35 PM EDT - 2 years ago

ProPhase Labs, Inc. (PRPH) Q4 2022 Earnings Call Transcript

ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022

Mar 28, 2023, 8:00 AM EDT - 2 years ago

ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022

ProPhase Labs Announces Data Presentation for its BE-Smart Esophageal Cancer Test

Mar 13, 2023, 8:00 AM EDT - 2 years ago

ProPhase Labs Announces Data Presentation for its BE-Smart Esophageal Cancer Test

ProPhase Labs: Lots Of Moving Pieces

Mar 2, 2023, 1:39 PM EST - 2 years ago

ProPhase Labs: Lots Of Moving Pieces

ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test

Dec 19, 2022, 8:30 AM EST - 2 years ago

ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test